引用次数
引用: 20,639
H-指数: 76
I10-指数 : 280
出版物: 778
Prevalence of Sleep Disturbances, Fatigue, Anxiety and Depression in Multiple Sclerosis (MS) (P1.128)
Sebastian Schimrigk , Alexander Dressel , Ulf Kallweit , Sven Rupprecht
Neurology 84
1
2015
Carbamazepine-Phenprocoumon Interaction
Tobias Böttcher , Johannes Buchmann , Uwe-Klaus Zettl , Reiner Benecke
European Neurology 38 ( 2) 132 -133
4
1997
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis
Susanne Vogler , René Goedde , Bianca Miterski , Ralf Gold
Journal of Molecular Medicine 83 ( 10) 806 -811
74
2005
State of the Art : Multiple Sklerose
Uwe K. Zettl
Fortschritte Der Neurologie Psychiatrie 75 ( 9) 6 -8
2007
Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue-Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers.
Dirk Reske , Robert Patejdl , Jürgen Faiss , Wolfgang Kristoferitsch
Biomolecules 11 ( 3) 393
2021
TPP2 mutation associated with sterile brain inflammation mimicking MS.
Eva M. Reinthaler , Elisabeth Graf , Tobias Zrzavy , Thomas Wieland
Neurology Genetics 4 ( 6)
5
2018
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
Marta F. Bustamante , Carlos Morcillo-Suárez , Sunny Malhotra , Jordi Rio
Neuroimmunology and Neuroinflammation 2 ( 5) 1 -6
15
2015
Treatment choices and neuropsychological symptoms of a large cohort of early MS.
Olga von Bismarck , Theresa Dankowski , Björn Ambrosius , Nicole Hessler
Neuroimmunology and Neuroinflammation 5 ( 3)
35
2018
Genetic determinants of the humoral immune response in MS.
Christiane Gasperi , Till F.M. Andlauer , Ana Keating , Benjamin Knier
Neuroimmunology and Neuroinflammation 7 ( 5)
1
2020
Is APOE ε4 associated with cognitive performance in early MS
Sinah Engel , Christiane Graetz , Anke Salmen , Muthuraman Muthuraman
Neuroimmunology and Neuroinflammation 7 ( 4)
1
2020
Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics.
Uwe K. Zettl , Franziska Di Pauli , Birgit Taumberger , Stefan Wietek
Journal of Neuroimmunology 277 ( 1) 145 -152
3
2014
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis
Steffi Grey (née Cotte) , Anke Salmen (née Stroet) , Nico von Ahsen , Michaela Starck
Journal of Neuroimmunology 278 277 -279
12
2015
Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
Ahmed Abdelhak , Tilman Hottenrott , Estrella Morenas-Rodríguez , Marc Suárez-Calvet
Frontiers in Neurology 10 280
78
2019
Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis
Hayrettin Tumani , Florian Deisenhammer , Gavin Giovannoni , Ralf Gold
Annals of Neurology 70 ( 3) 520 -520
52
2011
Fingolimod treatment for multiple sclerosis Patients What Do We Do with Varicella?
Alexander Winkelmann , Micha Loebermann , Emil C. Reisinger , Hans Peter Hartung
Annals of Neurology 70 ( 4) 673 -674
16
2011
Lymphocyte subpopulations, oxidative burst and Apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-β
Eilhard Mix , Katja Stefan , Jaqueline Höppner , Thomas Klauer
Autoimmunity 36 ( 5) 291 -305
13
2003
Comparison of three different proliferation assays for mouse myoblast cultures.
Matthias Wittstock , Charlotte Rehfeldt , Eilhard Mix , Uwe K. Zettl
Analytical Biochemistry 292 ( 1) 166 -169
11
2001
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Uwe K. Zettl , Thomas Henze , Ute Essner , Peter Flachenecker
European Journal of Health Economics 15 ( 9) 953 -966
18
2014
Independent replication of STAT3 association with multiple sclerosis risk in a large German case–control sample
Christina M. Lill , Brit-Maren M. Schjeide , Denis A. Akkad , Paul Blaschke
Neurogenetics 13 ( 1) 83 -86
18
2012
Assessment of microRNA-related SNP effects in the 3′ untranslated region of the IL22RA2 risk locus in multiple sclerosis
Orhan Aktas , Peter Lohse , Mathias Buttmann , Tania Kümpfel
neurogenetics 15 ( 2) 129 -134
15
2014